Literature DB >> 21326281

Isolated hypogonadotropic hypogonadism with SOX2 mutation and anophthalmia/microphthalmia in offspring.

Zornitza Stark1, Rebecca Storen, Bruce Bennetts, Ravi Savarirayan, Robyn V Jamieson.   

Abstract

Isolated hypogonadotropic hypogonadism (IHH) is a genetically heterogeneous condition in which patients frequently require assisted reproduction to achieve fertility. In patients with IHH who are otherwise well, no particular increased risk of congenital anomalies in the resultant offspring has been highlighted. Heterozygous mutations in SOX2 are the commonest single-gene cause of anophthalmia/microphthalmia (A/M) and sometimes result in pituitary abnormalities. We report a family with a novel frameshift mutation in the SOX2 transactivation domain, p.Gly280AlafsX91, resulting in bilateral anophthalmia and subtle endocrinological abnormalities in a male sibling, and unilateral microphthalmia in a female sibling. The mutation is present in their mother who has IHH, but has no eye disorders or other anomalies. She underwent assisted reproduction to achieve fertility. This report has important implications for the evaluation of patients with IHH, particularly in the setting of planned infertility treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21326281      PMCID: PMC3137491          DOI: 10.1038/ejhg.2011.11

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  26 in total

1.  A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules.

Authors:  B Franco; S Guioli; A Pragliola; B Incerti; B Bardoni; R Tonlorenzi; R Carrozzo; E Maestrini; M Pieretti; P Taillon-Miller; C J Brown; H F Willard; C Lawrence; M Graziella Persico; G Camerino; A Ballabio
Journal:  Nature       Date:  1991-10-10       Impact factor: 49.962

Review 2.  Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations.

Authors:  S B Seminara; F J Hayes; W F Crowley
Journal:  Endocr Rev       Date:  1998-10       Impact factor: 19.871

3.  A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor.

Authors:  N de Roux; J Young; M Misrahi; R Genet; P Chanson; G Schaison; E Milgrom
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

4.  WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.

Authors:  Hyung-Goo Kim; Jang-Won Ahn; Ingo Kurth; Reinhard Ullmann; Hyun-Taek Kim; Anita Kulharya; Kyung-Soo Ha; Yasuhide Itokawa; Irene Meliciani; Wolfgang Wenzel; Deresa Lee; Georg Rosenberger; Metin Ozata; David P Bick; Richard J Sherins; Takahiro Nagase; Mustafa Tekin; Soo-Hyun Kim; Cheol-Hee Kim; Hans-Hilger Ropers; James F Gusella; Vera Kalscheuer; Cheol Yong Choi; Lawrence C Layman
Journal:  Am J Hum Genet       Date:  2010-10-08       Impact factor: 11.025

5.  Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54.

Authors:  Nicolas de Roux; Emmanuelle Genin; Jean-Claude Carel; Fumihiko Matsuda; Jean-Louis Chaussain; Edwin Milgrom
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-27       Impact factor: 11.205

6.  Characterization of the human nasal embryonic LHRH factor gene, NELF, and a mutation screening among 65 patients with idiopathic hypogonadotropic hypogonadism (IHH).

Authors:  Kiyonori Miura; James S Acierno; Stephanie B Seminara
Journal:  J Hum Genet       Date:  2004       Impact factor: 3.172

7.  SOX2 anophthalmia syndrome.

Authors:  Nicola K Ragge; Birgit Lorenz; Adele Schneider; Kate Bushby; Luisa de Sanctis; Ugo de Sanctis; Alison Salt; J Richard O Collin; Anthony J Vivian; Samantha L Free; Pamela Thompson; Kathleen A Williamson; Sanjay M Sisodiya; Veronica van Heyningen; David R Fitzpatrick
Journal:  Am J Med Genet A       Date:  2005-05-15       Impact factor: 2.802

8.  Mutations in SOX2 cause anophthalmia.

Authors:  Judy Fantes; Nicola K Ragge; Sally-Ann Lynch; Niolette I McGill; J Richard O Collin; Patricia N Howard-Peebles; Caroline Hayward; Anthony J Vivian; Kathy Williamson; Veronica van Heyningen; David R FitzPatrick
Journal:  Nat Genet       Date:  2003-03-03       Impact factor: 38.330

9.  Recurrence of SOX2 anophthalmia syndrome with gonosomal mosaicism in a phenotypically normal mother.

Authors:  Laurence Faivre; Kathleen A Williamson; Valérie Faber; Nicole Laurent; Marianne Grimaldi; Christel Thauvin-Robinet; Christine Durand; Francine Mugneret; Jean-Bernard Gouyon; Alain Bron; Frédéric Huet; Caroline Hayward; Veronica van Heyningen; David R Fitzpatrick
Journal:  Am J Med Genet A       Date:  2006-03-15       Impact factor: 2.802

10.  The cDNA sequence and chromosomal location of the human SOX2 gene.

Authors:  M Stevanovic; O Zuffardi; J Collignon; R Lovell-Badge; P Goodfellow
Journal:  Mamm Genome       Date:  1994-10       Impact factor: 2.957

View more
  9 in total

Review 1.  Eye development genes and known syndromes.

Authors:  Anne M Slavotinek
Journal:  Mol Genet Metab       Date:  2011-09-29       Impact factor: 4.797

2.  Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia.

Authors:  Taneli Raivio; Magdalena Avbelj; Mark J McCabe; Christopher J Romero; Andrew A Dwyer; Johanna Tommiska; Gerasimos P Sykiotis; Louise C Gregory; Daniel Diaczok; Vaitsa Tziaferi; Mariet W Elting; Raja Padidela; Lacey Plummer; Cecilia Martin; Bihua Feng; Chengkang Zhang; Qun-Yong Zhou; Huaibin Chen; Moosa Mohammadi; Richard Quinton; Yisrael Sidis; Sally Radovick; Mehul T Dattani; Nelly Pitteloud
Journal:  J Clin Endocrinol Metab       Date:  2012-02-08       Impact factor: 5.958

3.  Mutation spectrum and phenotypic variation in nine patients with SOX2 abnormalities.

Authors:  Junichi Suzuki; Noriyuki Azuma; Sumito Dateki; Shun Soneda; Koji Muroya; Yukiyo Yamamoto; Reiko Saito; Shinichiro Sano; Toshiro Nagai; Hiroshi Wada; Akira Endo; Tatsuhiko Urakami; Tsutomu Ogata; Maki Fukami
Journal:  J Hum Genet       Date:  2014-05-08       Impact factor: 3.172

Review 4.  Genetics of syndromic ocular coloboma: CHARGE and COACH syndromes.

Authors:  Aman George; Tiziana Cogliati; Brian P Brooks
Journal:  Exp Eye Res       Date:  2020-02-04       Impact factor: 3.467

Review 5.  Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era.

Authors:  Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper
Journal:  Endocr Rev       Date:  2016-11-09       Impact factor: 19.871

6.  Genetic Overlap between Holoprosencephaly and Kallmann Syndrome.

Authors:  K Vaaralahti; T Raivio; R Koivu; L Valanne; E-M Laitinen; J Tommiska
Journal:  Mol Syndromol       Date:  2012-05-16

7.  Review of 37 patients with SOX2 pathogenic variants collected by the Anophthalmia/Microphthalmia Clinical Registry and DNA research study.

Authors:  Louise Amlie-Wolf; Tanya Bardakjian; Sarina M Kopinsky; Linda M Reis; Elena V Semina; Adele Schneider
Journal:  Am J Med Genet A       Date:  2021-09-25       Impact factor: 2.578

Review 8.  Congenital Hypopituitarism During the Neonatal Period: Epidemiology, Pathogenesis, Therapeutic Options, and Outcome.

Authors:  Laura Bosch I Ara; Harshini Katugampola; Mehul T Dattani
Journal:  Front Pediatr       Date:  2021-02-02       Impact factor: 3.418

9.  Clinical and mutation analysis of 51 probands with anophthalmia and/or severe microphthalmia from a single center.

Authors:  Christina Gerth-Kahlert; Kathleen Williamson; Morad Ansari; Jacqueline K Rainger; Volker Hingst; Theodor Zimmermann; Stefani Tech; Rudolf F Guthoff; Veronica van Heyningen; David R Fitzpatrick
Journal:  Mol Genet Genomic Med       Date:  2013-03-27       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.